Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Find generic entry opportunities
Manage your formulary budget
|Title:||Method for administering drug to gastrointestinal tract|
|Abstract:||A dosage form is disclosed that comprises means inside the dosage form for providing a substantially drug-free interval before the dosage form delivers a drug from inside the dosage form. The dosage form in an embodiment comprises a drug on the exterior of the dosage form, which drug is available for immediate delivery.|
|Inventor(s):||Wong; Patrick S.-L. (Palo Alto, CA), Theeuwes; Felix (Los Altos, CA), Ayer; Atul Devdatt (Palo Alto, CA), Kuczynski; Anthony L. (Palo Alto, CA)|
|Assignee:||ALZA Corporation (Palo Alto, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Device; Composition; Dosage form;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.